MARKET

SNPX

SNPX

SYNAPTOGENIX
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.80
-1.30
-14.29%
Pre Market: 7.77 -0.03 -0.38% 07:00 07/30 EDT
OPEN
9.55
PREV CLOSE
9.10
HIGH
9.55
LOW
7.78
VOLUME
617
TURNOVER
--
52 WEEK HIGH
14.40
52 WEEK LOW
2.600
MARKET CAP
27.36M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Benzinga · 22h ago
74 Biggest Movers From Yesterday
Gainers
Benzinga · 3d ago
Synaptogenix Stock Drops After Unveiling Analyses Of Alzheimer's Candidate
Benzinga · 3d ago
12 Health Care Stocks Moving In Monday's Intraday Session
 
Benzinga · 3d ago
48 Stocks Moving In Monday's Mid-Day Session
Gainers Bit Digital, Inc. (NASDAQ: BTBT) gained 38% to $5.83 after the company announced it entered into a second strategic co-mining agreement with Digihost Technology Inc. The stock is also trading higher in sympathy with the price of Bitcoin.
Benzinga · 3d ago
Synaptogenix shares fall 19% following release of Alzheimer's candidate bryostatin analyses
Andrew Brookes/Cultura via Getty Images Shares of Synaptogenix ([[SNPX]] -19.0%) are down sharply in morning training after the company released additional analyses of its Alzheimer's candidate bryostatin showing that it
Seekingalpha · 3d ago
Tyme Technologies, Xenetic Biosciences leads healthcare gainers; ATI Physical Therapy, Iterum Therapeutic among major losers
Gainers: Tyme Technologies TYME +46%, Xenetic Biosciences XBIO +40%, IMV (IMV) +18%, Translate Bio (TBIO) +10%, Reviva Pharmaceuticals (RVPH) +9%.Losers: ATI Physical Therapy ATIP -40%, Iterum Therapeutics ITRM -36%, Intec Pharma (NTEC) -21%, NRx Pharmaceu...
Seekingalpha · 3d ago
UPDATE: Synaptogenix Will Hold Conference Call July 26 At 4:15 p.m. EDT To Discuss Bryostatin Trial Analyses
Also, as previously announced, Synaptogenix will hold a conference call for investors to discuss its abstract. The call will take place, today, Monday, July 26th at 4:15pm ET and will be hosted by the
Benzinga · 3d ago
More
No Data
Learn about the latest financial forecast of SNPX. Analyze the recent business situations of SYNAPTOGENIX through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
No Data

Webull offers kinds of Neurotrope BioScience Inc stock information, including NASDAQ:SNPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNPX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SNPX stock methods without spending real money on the virtual paper trading platform.